CINAMON DONLEY: Open Payments
NPI 1407136013 · FORT WAYNE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$514 in 17 payments from 11 companies in 2025. Trend: 2023 $481 · 2024 $358 · 2025 $514
Food & beverage: $514
| Company | Payments | Amount |
|---|---|---|
| SANOFI-AVENTIS U.S. LLC | 2 | $131 |
| Pharmacosmos Therapeutics Inc. | 1 | $104 |
| Astellas Pharma US Inc | 3 | $70 |
| Biogen, Inc. | 3 | $66 |
| Exeltis, USA Inc. | 2 | $33 |
| Dexcom, Inc. | 1 | $25 |
| PFIZER INC. | 1 | $25 |
| Aspira Women's Health Inc | 1 | $19 |
| Exact Sciences Corporation | 1 | $19 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
Products named: TZIELD, MONOFERRIC, Veozah, ZURZUVAE, SLYND, Dexcom G6 Transmitter, ABRYSVO, OVA1.
Industry payments across IN — which companies pay providers there.
